SCHEMBL29944014

SCHEMBL29944014

CC(C)Oc1ccc(C(=O)N2CCCCC2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.68
MEN1 O00255 4/20 0.68
HTT P42858 2/20 0.68
GAA P10253 1/20 0.68
HPGD P15428 9/20 0.66
ALDH1A1 P00352 8/20 0.65
KDM4E B2RXH2 2/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MAPT P10636 3/20 0.59
TP53 P04637 2/20 0.59
THRB P10828 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.57
LMNA P02545 2/20 0.55
HSD17B10 Q99714 2/20 0.55
DRD2 P14416 1/20 0.55
DRD3 P35462 1/20 0.55
TSHR P16473 1/20 0.54
POLB P06746 1/20 0.54
USP2 O75604 1/20 0.53
ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9432497 0.84 TP53 (0.54) KMT2AMEN1HTTGAAHPGD
SCHEMBL29944141 0.84 HPGD (0.65) KMT2AMEN1HTTHPGDALDH1A1
SCHEMBL2535536 0.81 HPGD (0.96) KMT2AMEN1HTTGAAHPGD
SCHEMBL7132525 0.80 HPGD (1.00) KMT2AMEN1HPGDALDH1A1L3MBTL1
SCHEMBL27479149 0.80 HPGD (1.00) KMT2AMEN1HPGDALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL5213430 0.80 HPGD (0.93) KMT2AMEN1HTTGAAHPGD
SCHEMBL2534411 0.80 HPGD (1.00) KMT2AMEN1HTTGAAHPGD
SCHEMBL3455395 0.79 POLB (0.68) KMT2AMEN1HPGDALDH1A1KDM4E
SCHEMBL17933979 0.79 GCK (0.64) KMT2AMEN1HTTGAAHPGD
SCHEMBL10721733 0.78 HPGD (0.95) KMT2AMEN1HPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230110003-A1 PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) Valo Health, LLC 2023-04-13 US disclosed
US-11479564-B2 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) VALO HEALTH, INC. (US) 2022-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230110003-A1 PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) NAMPT, NAPRT, NNMT KMT2A 888/4885MEN1 2895/4885HTT 791/4885
US-11479564-B2 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) NAMPT, NAPRT, NNMT KMT2A 888/4885MEN1 2895/4885HTT 791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.